Illinois CancerCare-Bloomington — Bloomington, Illinois

Illinois CancerCare-Bloomington is a clinical research site located in Bloomington, Illinois, United States 61704.

Crixeo Health Trust Score: 89/100 (GOOD). This profile has not yet been claimed by the site owner.

Illinois CancerCare-Bloomington has participated in 376 clinical trials with 243 currently active.

Therapeutic areas: Ovarian Granulosa Cell Tumor, Ovarian Gynandroblastoma, Ovarian Sertoli-Leydig Cell Tumor.

Sponsors: GOG Foundation, SWOG Cancer Research Network, National Cancer Institute (NCI).

Sponsor Feasibility Report

Trust Score: 89/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Illinois CancerCare-Bloomington?

Illinois CancerCare-Bloomington has a Crixeo Trust Score of 89/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Illinois CancerCare-Bloomington conducted?

Illinois CancerCare-Bloomington has 376 clinical trials on record, with 243 currently active. Their work covers Ovarian Granulosa Cell Tumor, Ovarian Gynandroblastoma, Ovarian Sertoli-Leydig Cell Tumor.

Is Illinois CancerCare-Bloomington accredited by Crixeo Health?

Illinois CancerCare-Bloomington has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Illinois CancerCare-Bloomington?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.